Ando, Toshinori http://orcid.org/0000-0002-3141-8173
Arang, Nadia http://orcid.org/0000-0002-8167-2188
Wang, Zhiyong http://orcid.org/0000-0002-3574-6078
Costea, Daniela Elena http://orcid.org/0000-0001-7673-0358
Feng, Xiaodong
Goto, Yusuke
Izumi, Hiroki
Gilardi, Mara
Ando, Kazuyo
Gutkind, J. Silvio http://orcid.org/0000-0002-5150-4482
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (R01DE026644, R01DE026870)
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research
Article History
Received: 5 September 2021
Accepted: 1 October 2021
First Online: 1 November 2021
Competing interests
: The authors declare the following competing interests: J.S.G. is a member of the advisory board of Oncoceutics, Domain Therapeutics, and Vividion. The remaining authors declare no competing interests.